Abstract
Alström syndrome is an autosomal recessive syndromic genetic disorder caused by mutations in the ALMS1 gene. Sensorineural hearing loss occurs in greater than 85% of patients. Histopathology of the inner ear abnormalities in the human has not previously been fully described. Histopathology of the inner ear in Alström syndrome is presented in two genetically confirmed cases. The predominant histopathologic correlates of the sensorineural loss were degeneration of the organ of Corti, both inner and outer hair cells, degeneration of spiral ganglion cells, and atrophy of the stria vascularis and spiral ligament.
Keywords: Alström, ALMS1, human, histopathology, inner ear
Introduction
Alström syndrome, first described in 1959 [Alström et al, 1959] is a rare autosomal recessive genetic disorder caused by mutations in the ALMS1 gene [Collin, et al 2002; Hearn, et al 2002]. The clinical phenotype includes cone dystrophy leading to photophobia, nystagmus, usually beginning in infancy. The retinal dystrophy progresses during childhood to include rod involvement and deteriorating visual acuity. Complete loss of vision occurs by the second decade. Greater than 85% of patients present with bilateral sensorineural hearing loss, usually beginning in the first decade of life. The hearing loss is often compounded by chronic otitis media and glue ear [Alström et al, 1959, Marshall et al 2005, Marshall et al 2007,Welsh 2007, Marshall et al 2011]. Other clinical features include truncal obesity, type 2 diabetes mellitus in 95% of children over the age of 15 years, hypertriglyceridemia, hypercholesterolemia, dilated or restrictive cardiomyopathy, hypogonadism, glomerulosclerosis leading to progressive renal failure, steatosis, steatohepatitis, or cirrhosis of the liver [Marshall et al, 2011]. Although sensorineural hearing loss is common in Alström syndrome, the histopathology of the inner ear in the human has not been fully described. A brief description of the otopathology of cases 1 and 2 of this report can be found in Merchant and Nadol (2010a).
In a mouse model for Alström syndrome (Collin et al 2005), the cellular localization of ALMS1 to the basal bodies of hair cells suggests a role in ciliary function. In addition, planar polarity abnormalities of hair cell sterociliary bundles were noted. Abnormalities were detected in the ciliary bundles and dysfunction of the stria vascularis was seen in the homozygous mouse model (Alms1−/−). Progressive sensorineural hearing loss was demonstrated by ABR thresholds and DPOAE levels. Further, although initial ciliogenesis appeared normal in the ALMS1 −/− mouse, abnormal positioning of the kinocilium resulted in an accelerated loss of outer hair cells from the organ of Corti and degeneration of the stria vascularis.
Herein, we report the histopathology of the inner ear in two well-documented human cases of Alström syndrome.
MATERIALS AND METHODS
Case histories
Case 1
This 42 year-old woman with genetically confirmed Alström syndrome, developed a hearing loss in the first decade of life. She subsequently wore hearing aids throughout life. There was a slowly progressive sensorineural loss identified between the ages of 34 and 41. Word discrimination scores of 84% were recorded in both ears at age 38 ears. An audiogram done at age 41, one year before death (Fig. 1), demonstrated a bilateral, symmetric, sensorineural hearing loss of approximately 90dB, PTA.
The diagnosis of Alström syndrome was made soon after birth based on her clinical presentation and confirmed thereafter by genetic testing. She carried two heterozygous truncating mutations: c.2822T>A; p.Leu941* in exon 8 and c.11005C>T;p.Gln3669* in exon 16. As an infant she demonstrated photophobia and pendular nystagmus, progressive visual loss, and total blindness with bilateral cataracts before the age of 30 years. At nine months of age she experienced sudden dilated cardiomyopathy and congestive heart failure which resolved in the first year of life. At age 14, congestive heart failure recurred requiring multiple cardioversions for paroxysmal atrial fibrillation and mild dilation. She was hypertensive. She had multiple episodes of pneumonia and pulmonary hypertension. She developed hyperinsulinemia and acanthosis nigricans as a child, and type 2 diabetes mellitus in her teenage years. She was obese and short statured as an adult with a BMI of 32.9 (greater than 95th percentile). Endocrine disturbances included hypothyroidism, hyperandrogenism, and hirsuitism. She had massive hepatomegaly. She had chronic renal failure since the age of 16 and succumbed at age 42 to pulmonary failure and end stage renal failure. The renal pathology seen in Alstrom syndrome has been described (Izzi C et al 2011).
Autopsy findings included bilateral bronchopneumonia, acute respiratory distress syndrome, micronodular cirrhosis of the liver with fatty changes, splenomegaly, dilated cardiomyopathy, and atrophy of the optic nerves.
The patient's sister had a similar audiometric pattern and at age 21 years demonstrated a pure tone average of approximately 80dB in both ears, and at age 35, the threshold was 90dB on the left and 80dB on the right. Word discrimination scores were not tested.
Case 2
This 29 year-old man developed hearing loss first detected at the age of seven years at which time he was fitted with hearing aids. Auditory evoked brainstem responses obtained at age 12 estimated a threshold of 32dB on the right and 8dB on the left. An audiogram was done at age 20 (Fig. 2). This demonstrated predominantly mid-frequency, bilateral symmetric sensorineural loss with a speech reception threshold of 60dB and word recognition of 100%.
The diagnosis of Alström syndrome was made based on his clinical presentation at the age of 8 years, and was confirmed by genetic testing. He had two frameshift mutations in exon 17: c.11618_11619delCT; Ser3873Tyrfs*19 and c.11651_11652insGTTA; p.Asn3885Leufs*9. As an infant, his first symptoms were nystagmus and photophobia. He developed sudden onset of cardiomyopathy at two months of age which resolved before the age of two years. His congestive heart failure and cardiac arrhythmia recurred at age 16 years. He complained of episodic dizziness and disorientation. He was obese, with a BMI of 29.4 (greater than 90th percentile) as an adult. He had short stature, type 2 diabetes mellitus, hypothyroidism, hypogonadism, low testosterone levels, and dyslipidemia. He had reactive airway disease throughout childhood, with frequent episodes of bronchitis and pneumonia, and as an adult, chronic obstructive pulmonary disease and acute respiratory distress syndrome. He died at the age of 29 with end stage renal failure and respiratory failure.
Autopsy findings included diffuse atrophy of endocrine glands, hepatic cirrhosis with splenomegaly and portal hypertension and hypertrophic cardiomyopathy.
Otoacoustic emission testing was not done in either patient.
Histologic preparation
The temporal bones were removed at autopsy. The temporal bones from case 1 were fixed in 10% buffered formalin whereas in case 2, the specimens were post-fixed in Bouins fixative (picric acid) after partial decalcification in CAL-EXII (Fisher Scientific) for four months (formic acid in formaldehyde). The specimens were decalcified in ethylenediamine tetraacetic acid, dehydrated in graded alcohols and embedded in celloidin.
The specimens were serially sectioned in the horizontal (axial) plane at an average thickness of 20 micrometers. Every tenth section was stained with hematoxylin and eosin and mounted on glass slides. These semiserial sections were then reconstructed by a conventional 2-dimensional method, including counting of neurons of the four segments of the spiral ganglion (Guild 1921; Merchant and Nadol 2010b).
Histopathology
Case 1
The histopathology was similar on both sides and hence will be described together. The right and left temporal bones were well pneumatized, including the petrous apex. There was considerable postmortem artifact and autolysis. The estimated time was 36 to 48 hours between death and fixation.
Cochlea
The cochleae consisted of 2.5 turns. The cochlear duct measured 33.3mm in length on the right and 33.1mm on the left. There was severe and diffuse atrophy of the organ of Corti in all three turns (Figs. 3-5). In both ears, the organ of Corti was largely reduced to a flat layer of epithelial cells overlying the basilar membrane (Fig. 4), or a mound of cells with no identifiable neuroepithelial elements (Fig. 5). On the left side, there were small areas of residual organ of Corti in which both inner and outer hair cells were visible (Fig. 6). On both the left and right side, the tectorial membrane was artifactually detached from the limbus (Fig. 4). Despite considerable post-mortem artifact, atrophy of the stria vascularis and spiral ligament could be identified (Figs. 4,6).
Cochlear neurons
Rosenthal's canal measured 14.5mm in length on the right and 13.1mm on the left. There was degeneration of the spiral ganglion cells, particularly in the basal turn (Figs. 3,7). The spiral ganglion cell count on the left side was 13,865, representing 50% of normal for age, and on the right side, 14,647 cells, representing 53% of normal for age.
Vestibular system
Despite considerable autolysis, an intact neuroepithelium was identified in all five vestibular end organs in both ears. Scarpa's ganglion and its dendritic processes appeared normal.
The facial nerve, middle ear, mastoid, and tympanic membrane appeared normal.
The histopathologic correlate of hearing loss in Case 1, was a diffuse degeneration of the organ of Corti with only a few hair cells, both inner and outer, remaining throughout the cochlea. There was moderate degeneration of the spiral ganglion, particularly in the basal turn on both sides, and moderate degeneration of the stria vascularis and spiral ligament, although this was difficult to more precisely quantify because of significant postmortem artifact.
Case 2
The artifact was more severe in this case due to postmortem autolysis and fixation technique. The estimated time between death and fixation was 17 hours. However, the fixation was adequate to determine that similar to case 1, the predominant histopathologic correlate of hearing loss was diffuse and severe atrophy of cochlear hair cells, both inner and outer. There was also atrophy of the stria vascularis and spiral ligament similar to Case 1. Likewise, there was degeneration of the spiral ganglion cells, particularly in the basal turn. The spiral ganglion cell count on the right side was 7,110, approximately 22% of normal for age, and on the left side, 7,866, approximately 25% of normal for age. There was no significant pathology identified in the vestibular end organs.
In summary, the audiometric pattern in both cases consisted of a sensorineural hearing loss with a midfrequency predominance. Similarly, the histopathologic correlate of hearing loss in both cases was diffuse and severe degeneration of the organ of Corti with very few remaining hair cells present. There was also moderate degeneration and loss of spiral ganglion cells, particularly in the basal turn in both cases, and moderate atrophy of the stria vascularis and spiral ligament.
Discussion
In both cases, the predominant histopathologic correlate of the sensorineural hearing loss was degeneration of the organ of Corti with loss of inner and outer hair cells. This is consistent with the findings of Jagger D et al (2011), who described loss of outer hair cells in the Alström Syndrome mouse model of Alms1 −/−. However, in the animal model, significant preservation of outer hair cells in the apex was seen in the seven month old Alms1 −/− mouse. In this mouse model, a selective loss of outer hair cells was identified, whereas in the human, both inner and outer hair cells were lost. This phenotypic difference between the mouse model and the human may be due to longer duration of hearing loss in the human cases.
In the mouse model (Jagger D et al 2011), the mice progressively lost distortion product otoacoustic emissions, also suggesting an abnormality in the outer hair cells. In a recent clinical report (Bahmad JRF et al 2014), otoacoustic emissions were also found to be absent in two siblings with Alstrom syndrome while auditory brainstem responses were bilaterally normal, also suggesting a hair cell lesion. Thus, the otoacoustic emission findings both in the animal model and at least some cases of Alstrom syndrome, is consistent with a primary lesion at the level of the organ of Corti, specifically outer hair cells.
The mouse model and both human cases described here demonstrated a degeneration of the stria vascularis, probably not sufficient in the human to significantly affect hearing thresholds.
In addition to both inner and outer hair cell loss in the human, there was a significant loss of spiral ganglion cells, particularly in the basal turn, and more severe than can be attributed to the aging process only. This degeneration may be part of a species-specific expression of Alström syndrome in the human or may reflect neural degeneration secondary to hair cell loss.
Acknowledgments
Supported by:
NIH Grant HD036878 (JDM)
NIH Grant U24DC011943 (JBN)
REFERENCES
- 1.Alström CH, Hallgren B, Nilsson LB, Asander H. Retinal degeneration combined with obesity, diabetes mellitus, and neurogenous deafness: A specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome; a clinical, endocrinological, and genetic examination based on a large pedigree. Acta Psychiatr Neurol Scand Suppl. 1959;129:1–35. [PubMed] [Google Scholar]
- 2.Bahmad JRF, Costa CS, Teixeira MS, Barros-Fiho JD, Viana LM, Marshall JD. Familial Alstrom syndrome: a rare cause of bilateral progressive hearing loss. doi: 10.5935/1808-8694.20140023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P, Beck S, Boerkoel CF, Sicolo N, Martin M, Nishina PM, Naggert JK. Mutations in ALMS1 cause obesity, type 2 diabetes, and neurosensory degeneration in Alström syndrome. Nat Genet. 2002;31:74–78. doi: 10.1038/ng867. [DOI] [PubMed] [Google Scholar]
- 4.Collin GB, Cyr E, Bronson R, Marshall JD, Gifford EJ, Hicks W, Murray SA, Zheng QY, Smith RS, Nishina PM, Naggert JK. ALMS1 – disrupted mice recapitulate human Alström syndrome. Hum Mol Genet. 2005;14:2323–2333. doi: 10.1093/hmg/ddi235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Guild SR. A graphic reconstruction method for the study of the organ or Corti. Anat Rec. 1921;22:141–157. [Google Scholar]
- 6.Hearn T, Renforth GL, Spalluto C, Hanley NA, Piper K, Brickwood S, White C, Connolly V, Taylor JF, Russell-Eggitt I, Bonneau D, Walker M, Wilson DI. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat Genet Genet. 2002;31:79–83. doi: 10.1038/ng874. [DOI] [PubMed] [Google Scholar]
- 7.Izzy C, Maffei P, Milan G, Tardanico R, Foini P, Marshall JD, Scolari F. The case/ Familial occurrence of retinitis pigmentosa, deafness, and renal involvement. Kid Int. 2011;79:691–692. doi: 10.1038/ki.2010.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jagger D, Collin G, Kelly J, Towers E, Nevill G, Longo-Guess C, Benson J, Halsey K, Dolan D, Marshall J, Naggert J, Forge A. Alström syndrome protein ALMS1 localizes to the basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity. Hum Mol Genet. 2011;20:466–468. doi: 10.1093/hmg/ddq493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, MacDermott S, Russell-Eggit I, Shea SF, et al. New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch Int Med. 2005;165:675–683. doi: 10.1001/archinte.165.6.675. [DOI] [PubMed] [Google Scholar]
- 10.Marshall JD, Beck S, Maffei P, Naggert JK. Alström syndrome. Europ J Hum Gen. 2007;15:1193–1202. doi: 10.1038/sj.ejhg.5201933. [DOI] [PubMed] [Google Scholar]
- 11.Marshall JD, Hinman EG, Collin GB, Beck S, Cerqueira R, Maffei P, Milan G, Zhang W, Wilson DI, Hearn T, et al. Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlation in Alström syndrome. Hum Mutat. 2007;28:1114–1123. doi: 10.1002/humu.20577. [DOI] [PubMed] [Google Scholar]
- 12.Marshall JD, Maffei P, Collin GB, Naggert JK. Alström Syndrome; Genetics and clinical overview. Curr Genom. 2011:12;225–235. doi: 10.2174/138920211795677912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Merchant SN, Nadol JB Jr, editors. Schuknecht's Pathology of the Ear. third edition People's Medical Publishing House; USA: 2010a. pp. 174–175.pp. 689–690. [Google Scholar]
- 14.Merchant SN, Nadol JB Jr, editors. Schuknecht's Pathology of the Ear. third edition People's Medical Publishing House; USA: 2010b. pp. 34–40. [Google Scholar]
- 15.Welsh LW. Alström syndrome: Progressive deafness and blindness. Ann Otol Rhinol Laryngol. 2007;116:281–285. doi: 10.1177/000348940711600411. [DOI] [PubMed] [Google Scholar]